The U.S. authorities suggested American vacationers age 60 and older to not get a chikungunya vaccine because it investigates doable negative effects.
The Centers for Disease Control and Prevention and the Food and Drug Administration posted notices late final week on the vaccine, Valneva’s Ixchiq.
Chikungunya, unfold by the bites of contaminated mosquitoes, is a debilitating tropical sickness marked by fever and joint ache. About 100 to 200 instances are reported yearly amongst U.S. vacationers.
Last yr, the federal government started recommending the vaccine, which is made with weakened chikungunya virus, to U.S. adults who journey to international locations where chikungunya is an issue.
But final month, a panel of vaccine consultants who advise the CDC heard about an investigation into six folks 65 and older—most of them with different medical issues—who turned unwell with coronary heart or mind signs lower than every week after vaccination. More than 10 different comparable instances have been reported in folks from different international locations.
European regulators are also looking into the problem.
The U.S. advisers voted to challenge a precaution for folks 65 and older about getting the vaccine.
They additionally beneficial {that a} second chikungunya vaccine—Bavarian Nordic’s Vimkunya—be made out there for folks age 12 and older who’re touring to international locations where outbreaks of the mosquito-borne sickness are occurring. CDC officers haven’t but introduced whether or not they may settle for these suggestions.
© 2025 The Associated Press. This materials is probably not revealed, broadcast, rewritten or redistributed with out permission.
Citation:
US well being officers advise older vacationers to not get a chikungunya vaccine ( 13)
14
health-older-chikungunya-vaccine.html
.
. The content material is offered for info functions solely.